Healthcare Industry Reviews
7.7 Overall Score
CYNERIO

Healthcare cybersecurity · IoMT & clinical device risk

Cynerio

Recommend Scored Sep 2026 · Reviewed Sep 2026

Strong fit

  • Health systems with large connected device inventories across infusion, imaging, and monitoring
  • CISO teams that need clinical-context vulnerability prioritization
  • Networks still flat between biomedical and IT segments

Weak fit

  • Ambulatory groups with minimal IoMT footprint
  • Buyers who only need endpoint EDR on managed laptops
  • Organizations unwilling to engage biomed and clinical engineering in the rollout

Bottom line

Cynerio is a Recommend for hospitals that finally admit infusion pumps and imaging gear are on the network — and exploitable. Outcomes hinge on asset visibility and risk prioritization clinicians will accept; the product is strong in IoMT context. Implementation needs biomed partnership, not just a SOC license. Pricing sits in specialized healthcare security territory.

Score breakdown

8.0
IoMT visibility
7.8
Risk prioritization
7.4
Clinical context
7.2
Contract clarity
35% maps to outcomes
30% maps to product
20% maps to implementation
15% maps to pricing clarity

Score Analysis

  • IoMT visibility. You can't patch what you can't inventory. Discovery of clinical devices is the foundation buyers cite. We couldn't push higher because coverage still depends on network placement and passive sniffing limits.
  • Risk prioritization. CVE lists without clinical impact ranking overwhelm SOC teams. We held this when playbooks for quarantine still collide with patient-care uptime requirements.
  • Clinical context. Knowing a vulnerable pump is on a live ward changes response. Depth varies by device vendor fingerprinting quality.
  • Contract clarity. Specialized IoMT platforms price on bed count or device scale. Ask for year-two expansion math before you discover half the fleet.

Cynerio vs Competitors

Cynerio
IoMT discovery & clinical cyber risk
7.7
Overall Score
Imprivata
Identity-first clinical security
8.0
Overall Score
Claroty
Broader CPS/IoT security peer
—
Review forthcoming
Pricing Typically scaled to beds, sites, or discovered device counts. Include network sensor hardware and professional services in TCO. Compare against the cost of a clinical device outage, not against consumer AV pricing.

Methodology excerpt. Overall is a weighted 1–10 (Customer outcomes 35%, Product 30%, Implementation 20%, Pricing clarity 15%). Recommend labels: Highly recommend / Recommend / Conditional / Not recommended. See full methodology. This is an editorial review for healthcare-industry-reviews.com — not clinical advice, not a paid placement.